2011 SPRING - Modelling Human Biology, Disease and Intervention
DATE, LOCATION & HOST
The spring 2011 PRISME Forum Technical Meeting was held Wednesday, May 4, 2011, and was hosted by Wellcome Trust at its conference center in Hinxton, Cambridge, UK.
The meeting was preceded by a group dinner on Tuesday, May 3, 2011.
PRISM Forum Technical Meeting Chair: James McGurk, Daiichi-Sankyo
PRISM Forum Chair: Susie Stephens, J&J
PRIME Forum Chair: Hilda Gibson, AstraZeneca
Wellcome Trust
Meeting hosted by Wellcome Trust
3.-PRISM-Modspace-Presentation-04MAY11
4.-Selventa-PRISME-presentation
5.-Ferdinand-Rombout
7.-MODESIM-PRISME
8.-PRISM-Presentaiton-0.3-1
9.-Disease-Modeling-in-Oncology-MJ-04MAY11-PRISMe-ppt97
10.-Friend-PRISME-SIG
11.-David-Cook
2.-Mike-Krams
AS PPTs:
- Systems Biology for Product Testing – Julia Hoeng, Manager, PMI
- Adaptive Designs for dose-finding: Background and Case Study: Mike Krams, VP – Head of Neurology Franchise at Johnson & Johnson
- ModSPace: Analytical Knowledge Management – Richard Pugh, Technical Director and Co-Founder of Mango Solutions
- Disease Modelling – Ewan Hunter – Product Manager and Snr. Technical Sales Consultant, Selventa
- Cross Functional Modelling & Simulation – Ferdie Rombout – Director, DruDevO
- Quantitative Systems Pharmacology Modeling to accelerate drug development a tale of SGLT2i FOR Type 2 Diabetes – Paul DaSilva-Jardine, VP Cardiovascular and Metabolic Diseases Biology, Pfizer
- MODESIM (Modelling & SImulation at Novartis) – Paul Lewandowski, Associate Director Business Integration Manager, Novartis
- MODESIM (Modelling & SImulation at Novartis) – Chris Bingham, Application Service Manager, Modelling & Simulation at Novartis
- Drug/Disease Modelling & Simulation in Oncology – Mendel Jansen – Director, Translational Medicine & Clinical Pharmacology, Daiichi Sankyo
- Modelling & Simulation in Systems Biology: The Way Forward – Stephen Friend, President, Co-Founder & Director of Sage Bionetworks
- The Application of Systems Biology to Safety Assessment – David Cook, Associate Director, Global Safety Assessment, AstraZeneca